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Background: Traumatic injury to the central nervous system results in damage to tissue beyond the primary injury,
termed secondary degeneration. Key events thought to be associated with secondary degeneration involve aspects
of mitochondrial function which may be modulated by red/near-infrared irradiation therapy (R/NIR-IT), but precisely
how mitochondria are affected in vivo has not been investigated. Secondary degeneration was modelled by
transecting the dorsal aspect of the optic nerve in adult rats and mitochondrial ultrastructure in intact ventral optic
nerve vulnerable to secondary degeneration investigated with transmission electron microscopy.
Results: Despite reported increases in fission following central nervous system injury, we saw no change in
mitochondrial densities in optic nerve vulnerable to secondary degeneration in vivo. However, in axons, frequency
distributions of mitochondrial profile areas showed higher cumulative probabilities of smaller mitochondrial profiles at
day 1 after injury. Glial mitochondrial profiles did not exhibit changes in area, but a more elliptical mitochondrial shape
was observed at both day 1 and 7 following injury. Importantly, mitochondrial autophagic profiles were observed at
days 1 and 7 in optic nerve vulnerable to secondary degeneration in vivo. Citrate synthase activity was used as an
additional measure of mitochondrial mass in ventral optic nerve and was decreased at day 7, whereas mitochondrial
aconitase activity increased at day 1 and day 28 after injury in optic nerve vulnerable to secondary degeneration. R/NIR-
IT has been used to treat the injured central nervous system, with reported improvements in oxidative metabolism
suggesting mitochondrial involvement, but ultrastructural information is lacking. Here we show that R/NIR-IT of injured
animals resulted in distributions of mitochondrial areas and shape not significantly different from control and
significantly reduced mitochondrial autophagic profiles. R/NIR-IT also resulted in decreased citrate synthase activity
(day 7) and increased aconitase activity (day 1) in optic nerve vulnerable to secondary degeneration.
Conclusions: These findings suggest that mitochondrial structure and activity of enzymes of the citric acid cycle are
dynamically altered during secondary degeneration in vivo and R/NIR-IT may protect mitochondrial structure.Background
Acute injury to the central nervous system (CNS) is as-
sociated with secondary degeneration involving both
neurons and glia neighbouring the lesion, resulting in
further functional loss [1,2]. Mitochondrial dysfunction
is a critical component of CNS injury [3]. Intracellular* Correspondence: lindy.fitzgerald@uwa.edu.au
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stated.Ca2+ concentrations are disturbed both at and adjacent
to the injury [4], and mitochondria take up excess Ca2+
to maintain homeostasis in the cytosol [5]. However, ex-
cess mitochondrial Ca2+ may lead to the opening of the
mitochondrial permeability transition pore, with result-
ant impairment in mitochondrial function and metabolic
activity and/or cell death [6]. Further, mitochondria are a
major source of reactive oxygen species (ROS), the pro-
duction of which is increased with elevated mitochondrial
Ca2+ concentrations [7]. We have previously demonstrated
both altered Ca2+ distributions and oxidative stress in
white matter vulnerable to secondary degeneration [8].ral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
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energy needs of the cell, as well as perform their own
damage control, through their ability to divide (fission)
or fuse [9]. These processes are mediated by GTPases
[10] and are partly regulated by Ca2+ levels, with influx
of Ca2+ through voltage-gated Ca2+ channels causing
increased mitochondrial fission in vitro [11]. Impair-
ments in the balance between fission and fusion can lead
to disruptions in mitochondrial motility, ATP generation
and Ca2+ buffering. Such changes have been described in
a number of pathological situations, including neurode-
generative disorders, stroke models and conditions of
oxidative stress [12], but mitochondrial densities and
ultrastructure have not yet been assessed in vivo in white
matter vulnerable to secondary degeneration.
It was hypothesised that the balance of mitochondrial
fission/fusion would alter as a feature of secondary de-
generation in vivo. Accordingly, using the partial optic
nerve (ON) transection model of secondary degener-
ation [13,14], we assessed density of mitochondrial pro-
files to analyse possible changes in vivo [15]. Further,
area and shape of mitochondrial profiles were assessed,
as these aspects of mitochondrial structure have been
shown to be related to osmotic conditions, altered mito-
chondrial function and may also reflect changes associ-
ated with fission and/or fusion [16]. Citrate synthase
activity is widely used as an indicator of mitochondrial
mass [17] and was assessed here as an adjunct to the
ultrastructural analyses, together with mitochondrial
aconitase activity, which has been shown to be suscep-
tible to certain reactive species [18] that may contribute
to secondary degeneration.
Red/near-infrared irradiation therapy (R/NIR-IT, 630 -
1000 nm) has been used as a safe treatment for a range
of CNS disorders and injuries [19-21] and is currently
being assessed in clinical trials for stroke [22]. The
mitochondrial enzyme cytochrome c oxidase has been
posited as the most likely photoacceptor for R/NIR-
IT [23,24], and treatment is associated with improve-
ments in oxidative metabolism, including increased
ATP production [19,24,25]. We have demonstrated
that R/NIR-IT results in reduced oxidative stress and
preservation of function in ON vulnerable to second-
ary degeneration [26]. However, the effects of R/NIR-
IT on mitochondrial ultrastructure and citric acid
cycle enzyme activities in CNS injury and secondary
degeneration in vivo have not yet been assessed. Here
we show that mitochondria exhibit subtle ultrastruc-
tural changes during secondary degeneration, as well
as an increased appearance of mitochondrial autopha-
gic profiles. Following R/NIR-IT, the mitochondrial
area and shape changes seen during secondary degen-
eration were no longer observed, and mitochondrial
autophagic profiles were reduced.Results
Density of mitochondrial profiles did not change in areas
of ON vulnerable to secondary degeneration +/− R/NIR-IT
Mitochondria can respond to stress in part by altering
the balance between fission and fusion [15]. It was
hypothesised that such an alteration would be reflected
in a change of mitochondrial numbers following injury,
indicated by the number of mitochondrial profiles in
TEM images from transverse ON sections [27]. We
assessed mitochondrial profiles at 1 and 7 days after in-
jury, as we have already demonstrated that the oxidative
stress response is well established at 1 day [1] and mito-
chondrial ultrastructure changes as a response to oxida-
tive stress may be beginning to resolve at 7 days. The
densities of mitochondrial profiles were separately quan-
tified for axonal and glial cellular compartments. Axons
were clearly identified by the surrounding electron dense
myelin sheath and glial compartments were defined as
the non-axonal areas within the image (Figure 1B).
Mitochondria were identified on the basis of a clear
double membrane, increased electron density and/or the
presence of convolutions (Figure 1C). It was not neces-
sary to correct density values for ventral ON area as
there was no change in the area of the ventral region
observed with injury, at the time points assessed in
the current study (ANOVA, F = 0.1, p = 0.87, data not
shown). Furthermore, no significant differences between
control groups were detected (unhandled vs handled an-
imals) for any of the TEM outcomes (all p > 0.05); there-
fore data from these groups were pooled. There were no
significant changes in mean mitochondrial density with
injury or R/NIR-IT, in either axonal or glial cellular
compartments (Figure 1D, E; F = 1.2, p = 0.32 and F =
0.54, p = 0.71, respectively). This implies that mitochon-
drial fission was not a feature of secondary degeneration
in this model, at 1 and 7 days after injury.
Area and shape changes of mitochondrial profiles in ON
vulnerable to secondary degeneration +/− R/NIR-IT
Aspects of mitochondrial structure, including size and
shape, are related to function [16]. We therefore
assessed cross-sectional area of mitochondrial profiles
(Figure 1B) in order to detect changes occurring as a
consequence of secondary degeneration. Mean area of
mitochondrial profiles was not significantly different fol-
lowing PT injury or R/NIR-IT in either axons (Figure 2A,
F = 2.1, p = 0.11) or glia (Figure 2B, F = 0.69, p = 0.60).
However, comparison of frequency distributions of mito-
chondrial area (displayed as cumulative probabilities)
revealed subtle differences not apparent in means com-
parisons. At day 1 after PT, there was a significant
change in the distribution of areas of axonal mitochon-
drial profiles in ventral ON vulnerable to secondary
degeneration (Figure 2C, d = 0.17, p = 0.02), with an
Figure 1 Density of mitochondrial profiles in ON vulnerable to secondary degeneration +/− R/NIR-IT. (A) Transverse section (semi-thin) of
an ON lesion site, stained with 0.5% toluidine blue. The black bars are a schematic of the copper grid overlaying ultrathin sections and the arrow
represents the path taken during sampling from one ventral region, bounded by the grid; scale = 50 μm. (B) Representative electron micrograph
illustrating definition of axonal and glial cellular compartments, tracing of glial processes is shown in green. Diameters of mitochondria were
measured at the longest extent and a second measurement perpendicular to the first through the midline was made for assessment of
mitochondrial ellipticity (red). Area was measured by manually tracing around the outer membrane (yellow); scale = 1 μm. (C) Representative
images illustrating criteria for classification as mitochondria ie: double membrane, increased electron density and/ or convolutions (black arrows)
or excluded due to lack of double membrane (red arrow); scale = 1 μm. Mean densities of mitochondrial profiles did not change with injury or R/
NIR-IT in axons (D) or glia (E), p >0.05. Black dots represent means for each animal and the red line indicates the group mean.
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tochondria following injury. No significant change was
observed at day 7 compared to normal in axonal mi-
tochondria (Figure 2E, d = 0.07, p = 0.61). Following
R/NIR-IT, the frequency distribution of areas of axonal
mitochondrial profiles was no longer significantly differ-
ent from normal animals (d = 0.09, p = 0.45), and there
was a shift in the cumulative probabilities towards larger
mitochondria compared to injured animals (d = 0.16,
p = 0.03). There was no statistically significant effect ofR/NIR-IT on the distribution of axonal mitochondrial
area at day 7 (d = 0.14, p = 0.15). Mitochondria are gen-
erally longitudinally aligned along the ON [28]. There-
fore the lengths of axonal mitochondria were also
assessed in longitudinal sections from a separate cohort
of animals. Pilot data indicated that mitochondrial
length did not change at 1 day after injury in ON vulner-
able to secondary degeneration (mean ± S.E.M: normal =
0.98 ± 0.10 μm; PT day 1 = 0.82 ± 0.05 μm; t = 1.40,
p = 0.23).
Figure 2 Changes in mitochondrial profile cross-sectional area in secondary degeneration +/− R/NIR-IT. Mean area did not change with
either injury or R/NIR-IT in axons (A) or glia (B). At day 1 after PT, mitochondrial profiles with smaller areas became more frequent in axons, and
this was no longer observed following R/NIR-IT at this time (C). There were no changes in the distributions of glial mitochondria at day 1 (D). At
day 7, there was no change in the distribution of area of axonal mitochondrial profiles (E). R/NIR-IT resulted in an increased cumulative
probability of mitochondria with smaller cross-sectional areas compared to PT day 7 in glia, however neither the distributions of injured animals
(PT) or R/NIR-IT animals (PT 670 nm) were different from normal (F). *Significantly different at p≤ 0.05.
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mitochondrial profile areas was observed due to second-
ary degeneration at day 1 (Figure 2D, d = 0.11, p = 0.40),
or at day 7 (Figure 2F, d = 0.09, p = 0.43). Despite this,
and in contrast to effects observed in axonal compart-
ments, R/NIR-IT resulted in a reduction in glial mito-
chondrial profile area at day 7 after injury, as reflected
by an increase in the cumulative probability of smaller
mitochondria in injured animals (d = 0.27, p = 0.01).
However, the difference in distribution was notsignificantly different when compared to normal ani-
mals (d = 0.2, p = 0.17) (Figure 3F).
For every mitochondrial profile assessed, a ratio be-
tween the minimum and maximum diameter was gener-
ated (Figure 1B, 3A), providing a quantitative assessment
of mitochondrial profile shape. Ratios closer to 1 reflect
more circular profiles, while larger ratios represent more
elliptical shapes. Representative images of mitochondria
exhibiting different ratios are displayed in Figure 3A.
Similarly to analyses of mitochondrial profile area, there
Figure 3 Mitochondrial shape changes in secondary degeneration +/− R/NIR-IT. Representative images of shapes represented by common
ratios, scale = 200 nm (A). Representative images illustrating lack of change in mitochondrial profile shape with R/NIR-IT at day 1 in axons (B) and
more circular mitochondrial profiles with R/NIR-IT at day 7 in glia (C); scales = 500 nm.
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following PT injury or R/NIR-IT in axons (Figure 4A,
F = 2.01, p = 0.12) or glia (Figure 4B, F = 0.12, p = 0.13).
Analyses of frequency distributions of mitochondrial pro-
file shape showed that while there was a trend towards
more elliptical profiles, there were no statistically signifi-
cant changes in the distributions of mitochondrial profile
shape in secondary degeneration in axons at either day 1
(Figure 4C, d = 0.10, p = 0.06) or day 7 (Figure 4E,d = 0.07, p = 0.41). While R/NIR-IT had no effect on these
distributions when compared to injured animals in axons
at day 1 (Figure 4C, E, Figure 3B; d = 0.11, p = 0.08) or day
7 (d = 0.10, p = 0.15), distributions indicated an increas-
ingly elliptical shape compared to normal animals at day 1
(d = 0.17, p = 0.02) but not at day 7 (d = 0.10, p = 0.18).
In glia, the distribution of mitochondrial profile shapes
was significantly altered towards a higher probability of
more elliptical profiles (Figure 4D, d = 0.20, p = 0.04),
Figure 4 Quantification of mitochondrial shape changes in secondary degeneration +/- R/NIR-IT. Mean ratios of diameters did not
change with either injury or R/NIR-IT in axons (A) or glia (B). At day 1, there was no change in mitochondrial profile shape in axons (C), but
a higher probability of more elliptical profiles (signified by larger ratios) was observed in glia (D). Following R/NIR-IT, the distributions of
mitochondrial profile shape in glia were not significantly different from normal. At day 7 following injury, the distribution of mitochondrial profile
shape was not different compared to normal in axons (E), but again a higher cumulative probability of more elliptical profiles in glia was
observed (F); a change which was no longer detected after R/NIR-IT. *Significantly different at p ≤ 0.05.
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p = 0.03). Following R/NIR-IT, the distribution of mito-
chondrial profile shapes was significantly less elliptical
compared to the untreated group at 7 days after injury
(Figure 4F, 3C; d = 0.18, p = 0.02) and was no longer
significantly different from normal at either day 1
(Figure 4D, d = 0.13, p = 0.40) or day 7 (Figure 4F, d =
0.09, p = 0.84). R/NIR-IT did not significantly alter the
distribution of mitochondrial profile shape compared to
the untreated group at 1 day after injury (d = 0.11, p =
0.58), but distributions were also not different from nor-
mal (Figure 4D, d = 0.12, p = 0.40). This finding suggests
that R/NIR-IT either prevented the change in mitochon-
drial profile shape seen in secondary degeneration, or re-
stored normal shape.Mitochondrial autophagy in ON vulnerable to secondary
degeneration +/− R/NIR-IT
Ultrastructural analyses of mitochondria revealed a small
subset which featured second double membranes, very
high electro-density and/ or vacuole-like features, clearly
indicative of autophagic processes [29,30], and which
precluded their inclusion in density analyses described
to this point. The envelopment of mitochondria in
autophagic membranes is suggestive of their elimination
by mitophagy (Figure 5A-E). However definitive identifi-
cation of mitophagy (as opposed to other autophagic
elements) is hampered by lack of selective markers
applicable to both axons and glia [31], the fact that
structural features in TEM images can be equivocal and
that structural and chemical features of autophagy in
Figure 5 Mitochondrial autophagic profiles in ON vulnerable to secondary degeneration +/− R/NIR-IT. Accumulations of mitochondrial
autophagic profiles (red arrows) were seen especially at day 1 after PT (A, B). Occasionally, larger features reminiscent of autophagosomes were
observed (A, black arrow) and parts of the nerve appeared highly abnormal (*, B). Further representative images of mitochondria (identified by
their double membrane) enveloped by an additional double membrane (C, D, E, red arrows, classified as mitochondrial autophagic profiles) are
shown; scale bar = 1 μm unless otherwise stated on image. Number of mitochondrial autophagic profiles at day 1 (F): each black dot represents
one animal, and larger dots represent a higher frequency of that particular number of observations. There were significantly more observations of
mitochondrial autophagic profiles at day 1 after PT injury compared to normal, which was not significantly altered by R/NIR-IT. At day 7 there was
an increased incidence of mitochondrial autophagic profiles compared to normal and the incidence was decreased following R/NIR-IT (G). Note
that for this outcome, no distinction between glia and axons was made, due to the number of mitochondrial autophagic profiles in glia being
very low. *Significantly different at p≤ 0.05.
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[32]. Therefore, these structures were classified as mito-
chondrial autophagic profiles and their incidence quanti-
fied per field of view (30 fields of view/animal, Figure 4F,
G). The incidence of mitochondrial autophagic profiles
in ventral ON was significantly higher at days 1 and 7
after injury compared to normal (Figure 5F, G, F = 5.53,
p < 0.001; F = 34.98, p < 0.001, respectively). Treatment
with R/NIR-IT did not affect the incidence of mitochon-
drial autophagic profiles compared to injured animals at
day 1 (F = 0.42, p = 0.74). At day 7 however, R/NIR-IT
resulted in a smaller number of mitochondrial autopha-
gic profiles compared to injured animals (Figure 5G,F = 26.73, p < 0.01), with numbers not significantly differ-
ent from normal (F = 0.09, p = 0.77).
Aconitase and citrate synthase activities in ON following
PT injury +/− R/NIR-IT
The activities of the mitochondrial enzymes aconitase
and citrate synthase were assessed in homogenates of
both dorsal ON exposed to the primary injury and
ventral ON vulnerable to secondary degeneration (n = 6
pooled ONs/group). Aconitase activity has been shown
to be inhibited by certain species of ROS [18,33] and as
such has been used to indicate altered mitochondrial
function due to oxidative stress [34]. Citrate synthase
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chondrial density and size, to provide an additional
marker of mitochondrial content [17,35]. PT injury
led to significant differences in mean activity for both
aconitase (Figure 6A, V = 1.8, p < 0.001) and citrate
synthase (Figure 6B, V = 1.43, p < 0.001). Follow up
ANOVAs and Bonferroni post hoc tests demonstrated
significant increases in aconitase activity compared to
normal at days 1 and 28 after injury in ventral ON (F =
424.41, p < 0.001) and significant decreases in citrate
synthase activity compared to normal in ventral ON at
day 7 (F = 21.94, p < 0.001) and in dorsal ON at day 28
(F = 12.17, p = 0.002). No statistically significant differ-
ences in dorsal ON aconitase activity were detected (F =
5.9, p = 0.06), likely due to relatively high S.E.M in the
normal group (Figure 6A, B).
Following R/NIR-IT, aconitase activity was increased
in both dorsal and ventral ON (V = 0.935 p = 0.02)
at day 1 after injury (Figure 6C, F = 24.37, p = 0.01 and
F = 36.26, p < 0.01, for dorsal and ventral respectively).Figure 6 Aconitase and citrate synthase activities after PT injury +/−
vulnerable to secondary degeneration after PT injury compared to normal
ON (C). Citrate synthase activity (mean ± SEM) decreased after injury comp
*Significantly different at p≤ 0.05.R/NIR-IT also affected citrate synthase activity in both
dorsal and ventral ON as follows (V = 0.995, p < 0.001);
while activity was significantly decreased in ventral ON
at day 7 after injury (F = 768.19, p < 0.001) activity was
significantly increased in dorsal ON (F =149.55,
p < 0.001) (Figure 6D).
Discussion
We have demonstrated that in ON vulnerable to second-
ary degeneration, densities of mitochondrial profiles were
not altered, indicating no change to the balance of fission
and fusion. More detailed analyses of distributions of
mitochondrial size and shape revealed subtle alterations
during secondary degeneration. Axonal mitochondrial
profiles were smaller 1 day following injury, perhaps
indicating a tendency towards fission, or alternatively,
shrinkage in response to changing osmotic conditions. In
contrast, glial mitochondrial profile area did not change,
but profiles were more elliptical at days 1 and 7 after PT
injury. While the observation of elliptical profiles dependsR/NIR-IT. Aconitase activity (mean ± SEM) increased in ventral ON
(A) and with R/NIR-IT compared to PT day 1 in both ventral and dorsal
ared to normal (B) and following R/NIR-IT compared to PT at day 7 (D).
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elliptical profiles together with no change in area indicates
that on average, mitochondria in glia were becoming lon-
ger and thinner, perhaps indicating fusion. However the
lack of increase in density of mitochondrial profiles indi-
cates that these changes were relatively minor and marked
alteration in the balance of fission/fusion in ON vulner-
able to secondary degeneration at day 1 is unlikely. Our
findings are of interest as they are in contrast to
reported increases in fission as a consequence of stroke
[12], although changes at earlier time points may occur.
Importantly, there was a significant increase in the ap-
pearance of mitochondrial autophagic profiles at days 1
and 7 in ON vulnerable to secondary degeneration, as
has been reported in a range of CNS injury models
[29,30], indicating vulnerability of mitochondria to sec-
ondary degeneration.
The lack of change in citrate synthase activity in ON
at day 1 after injury reflected the unchanged density of
mitochondrial profiles at this time, indicating that mito-
chondrial volume was maintained. However, despite
constant mitochondrial density, citrate synthase activity
decreased in ventral ON at day 7, perhaps due to the
demonstrated inhibition of this enzyme by alkyl peroxyl
and alkoxyl radicals [36], which are elevated following
traumatic brain injury [37]. In contrast, we observed
increases in aconitase activity in ventral ON. Given that
we did not observe greater mitochondrial density in ven-
tral ON after injury, we can exclude that the increase
in aconitase reflects more mitochondria. Aconitase is
known to be inhibited by ROS such as superoxide [38],
H2O2 [18], and peroxynitrite [33]. Coupled with our
reported increase in MnSOD immunointensity at 1 and
7 days after partial ON transection [1], these data sug-
gest that superoxide levels are effectively controlled by
endogenous mechanisms in our model. An approxi-
mately 50% increase in aconitase activity has been
reported following repeated contractions of mouse skel-
etal muscle, despite increased ROS production [39], but
mechanisms are unclear and further work is required to
understand the effects of secondary degeneration on the
activity of citric acid cycle enzymes.
R/NIR-IT prevented the subtle decrease in axonal
mitochondrial profile size, suggesting that for this out-
come, normal mitochondrial ultrastructure was either
maintained despite injury, or restored within the first
24 hours with R/NIR-IT. Similarly, following R/NIR-IT
in PT injured ON, mitochondrial shape in glia was no
longer different from normal. Importantly, the appear-
ance of mitochondrial autophagic profiles observed in
ON vulnerable to secondary degeneration was also re-
duced by R/NIR-IT at day 7. The finding that R/NIR-IT
partly prevented the changes in mitochondrial ultra-
structure seen in secondary degeneration in vivo is inline with previous studies reporting beneficial effects of
R/NIR-IT on mitochondrial metabolism associated with
functional improvements. These include increased visual
pathway and whole-brain metabolism as assessed using
cytochrome c oxidase activity and oxygen consumption
[20], recovery of rod and cone-mediated function after
inhibition of cytochrome c oxidase with formic acid de-
rived from the in vivo breakdown of methanol [19], as
well as reductions in markers of oxidative stress [26,40].
Our findings suggest that these improvements in oxida-
tive metabolism with R/NIR-IT could be in part due to
preservation of normal mitochondrial structure, which
goes hand-in-hand with normal mitochondrial function
[15,41,42]. By extension, improvements in the structure
of mitochondria may explain the improvements in visual
function previously reported in our model following
R/NIR-IT [26].
Very few studies have examined the effect of R/NIR-IT
on mitochondrial morphology, and these have used
in vitro models of non-CNS systems. In human lympho-
cytes, irradiation with He-Ne laser (λmax = 632.8 nm)
resulted in the formation of giant, branched mitochon-
dria at 1 hour post-treatment [43]. These were shown to
be due to fusion of smaller mitochondria and proposed
to be more efficient at energy transfer [43]. Giant mito-
chondria have been described in rat axon hillocks [44],
with a characteristic diameter of approximately 1 μm,
but were not observed in the present study. Structural
changes of the giant mitochondrion normally present in
yeast cells after irradiation with He-Ne laser have also
been investigated [45] and it was found that eighteen
hours after irradiation, the mitochondrial matrix had ex-
panded, providing conditions more favourable to energy
transfer in the form of membrane potential. A similar
scenario could be responsible for a restoration of axonal
mitochondrial profiles to normal size by day 1 in the
current model and the increasingly elliptical shape of
mitochondria in axons compared to normal at day 1.
However, it is also possible that mitochondrial size was
simply maintained and/or increased via a protective ef-
fect due to increased cytochrome c oxidase activity, as
has been reported with R/NIR-IT [23,24], prevention of
reverse electron transport and maintenance of the mito-
chondrial permeability transition [7,46] or restoration of
normal osmotic conditions. R/NIR-IT also prevented the
shift towards more elliptical mitochondrial profiles that
was observed in glia at day 1 and 7 in ON vulnerable to
secondary degeneration. As a number of pathological
circumstances result in a transition from elliptical, rod-
like mitochondria to more rounded mitochondria, it is
unclear whether the increasingly elliptical shape seen
after PT injury reflects functional impairment, or is
perhaps a reflection of cytoskeletal changes following in-
jury [47-49]. Similarly, the altered citrate synthase
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ing R/NIR-IT could reflect impairment as a consequence
of irradiation, but the complexities in the responses to
injury of these enzymes indicates that more detailed ana-
lyses are required to understand these effects and ascer-
tain whether these changes in enzyme activity are more
or less important than the observed structural restora-
tions. Further, given the host of studies reporting benefi-
cial effects of R/NIR-IR on mitochondrial function, it is
unlikely that the observed alterations in enzyme activ-
ities are detrimental [20,24,50]. R/NIR-IT resulted in in-
creased relative matrix surface area in yeast
mitochondria [45] and this improves their aerobic cap-
acity [51], however assessment of cristae was beyond the
scope of the current study.Conclusions
Mitochondria exhibit both structural and functional
changes in secondary degeneration, which are likely to
play an important role in the pathophysiology of this
process. We have provided evidence that R/NIR-IT has
potentially beneficial effects on mitochondrial structure
in secondary degeneration and can also affect citric acid
cycle activity. Understanding the mechanism by which
R/NIR-IT exerts its positive effects on function is valu-
able, as this therapy is both clinically relevant and readily
translatable, offering an exciting candidate for treatment
of secondary degeneration following injury to the CNS.Methods
Animals and surgery
All experimental procedures conformed to ‘Principles of
Laboratory Animal Care’ and were approved by the Ani-
mal Ethics Committee of the University of Western
Australia. Adult female Piebald Virol Glaxo (PVG) rats
(160-200 g) obtained from the Animal Resource Centre
(Murdoch, WA) were housed in clear plastic cages with
food and water ad libitum under a standard 12 hour
light/dark cycle. Animals were anaesthetised with an in-
traperitoneal injection of xylazine (10 mg/kg, Troy La-
boratories Pty Ltd) and ketamine (50 mg/kg, Troy
Laboratories Pty Ltd) and euthanized with Euthal (active
constituent Pentobarbitone Sodium 160 mg/ml, Virbac
Australia Pty Ltd). Following anaesthesia, animals re-
ceived a partial transection (PT) to the right ON, as de-
scribed previously [14,52]. Briefly, a controlled 200 μm
cut to the dorsal surface of the optic nerve was made
with a radial keratotomy diamond knife (Geuder), ap-
proximately 1 mm behind the eye, with care taken to
minimise damage to the lachrymal glands or major
blood vessels. The animals recovered on a warming
blanket and were rehydrated with a subcutaneous injec-
tion of 1 ml phosphate buffered saline (PBS) as well astreated subcutaneously with an analgesic (carprofen,
4.0 mg/kg, Norbrook Australia Pty Ltd).
R/NIR-IT
R/NIR-IT was administered using a VET 75 LED array
(Quantum Devices) positioned 3 cm above and parallel
to the dorsal surface of the head of the animal, so that
the entire head was irradiated. Light was delivered with
a centre wavelength of 670 nm and a full-width at half
maximum bandwidth of approximately 22 nm emitting
5 joules of energy per 88-second dose at 60 mW/ cm2 at
a total fluence of 4.5 W. The array was air cooled.
Choice of treatment time and administration details
were based on the literature and beneficial effects previ-
ously described following ON injury [20,26,53]. Animals
were treated once per day for 30 minutes, with the first
treatment administered immediately following PT sur-
gery, while the animal was recovering from anaesthesia,
temperature maintained on a 37°C heat-pad. Subsequent
treatments involved loosely holding the un-anaesthetised
animal under the LED array, minimising stress and
preventing rises in body temperature; as measured by
rectal thermometer. Animals were euthanized and either
perfused or dissected (as described below) immediately
after completion of the final treatment session. Control
animals (in groups as described below) received sham
handling, under a cardboard box of the same dimensions
as the LED array.
Transmission electron microscopy (TEM) assessment of
mitochondrial ultrastructure: tissue preparation
Mitochondrial ultrastructure was assessed at two time
points post PT (day 1 or day 7). Three groups per time
point (n = 3-4/ group) received a PT of the ON, followed
by either R/NIR-IT (PT 670 nm), handling (PT handled)
or no further intervention (PT). The fourth group was
an uninjured, but handled control (Normal handled, day
1 only due to constraints of study size). An additional
group of completely normal (unhandled) animals was
also assessed. The study design is summarised in Table 1.
Animals were euthanized and transcardially perfused
with 150 ml 0.9% saline, followed by 150 ml of modified
Karnovsky’s fixative (2.5% glutaraldehyde, 1% parafor-
maldehyde, 0.15 M Sorenson’s Phosphate buffer, 2%
sucrose, pH = 7.2). ONs were dissected and stored in
Sorenson’s Phosphate buffer until post-fixed in 1%
osmium tetroxide (ProSciTech) in 0.15 M phosphate
buffer, 1 hr. Nerves were then dehydrated through
graded alcohols and propylene oxide before embedding
in epoxy resin. Nerves were sectioned in the transverse
plane on an Ultrotome NOVA microtome; ultrathin
100 nm sections were cut from the lesion site, collected
onto copper grids and stained with uranyl acetate, blot
dried and then stained with Reynold’s lead citrate for
Table 1 Experimental design for TEM study (transverse
sections)
Day 1 n animals
(mitochondria analysed)
Day 7 n animals
(mitochondria analysed)
Normal 4 (344)
Normal handled 4 (224) -
PT unhandled 4 (584) 4 (272)
PT handled 4 (398) 4 (306)
PT 670 nm 4 (466) 4 (327)
Total n 36 (2,921)
Note an additional day 1 cohort was used for longitudinal sections. TEM is
transmission electron microscopy. Numbers shown are animals (total number
of mitochondria analysed in transverse sections for each treatment or
injury group).
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mitochondrial length in longitudinal sections, assessing
normal animals and 1 day after PT injury (n = 3/group).
ON tissue was processed and sectioned as for transverse
sections, but sections were cut longitudinally.
TEM assessment of mitochondrial ultrastructure: image
acquisition and analysis
For each ON segment, a single section that clearly
contained the injury site was chosen for analysis. TEM as-
sessments were conducted by collecting 30 images for
transverse sections and 20 images for longitudinal sections
(using separate animal cohorts, as described above) in this
single section of ON at the injury site, following a
predetermined sampling pattern in the ventral region,
similar to that previously described [54] and as illustrated
in Figure 1A. Transverse sections were imaged using a
Philips CM-10 TEM (Eindhoven, The Netherlands) at-
tached to an Olympus Megaview III camera (1376x1032
pixels), at an accelerating voltage of 80 kV at 25000x mag-
nification, corresponding to a field of view size of
10.4 μm2. The total area imaged per section was 312 μm2,
which corresponds to approximately 0.3% of the ventral
ON area, as used in assessments of myelination of axons
at the ultrastructural level [54,55]. Longitudinal sections
were imaged using a JEOL JEM-2001 (Japan) TEM at-
tached to an Oris SC1000 CCD camera (40008x2672
pixels) at an accelerating voltage of 120 kV, at 4000x mag-
nification, which on this microscope corresponded to a
field of view size of 34.2 μm2.
All visible mitochondria in all images were analysed
(>220 mitochondria/group for transverse sections and >50
mitochondria/group for longitudinal sections). A mito-
chondrion was defined as a structure displaying a double
membrane, being darker (more electron-dense) compared
to the surroundings and/or displaying convolutions [56].
Mitochondrial length and the cross-sectional area of each
mitochondrial profile (the latter as measured by manually
tracing around the outer membrane) were assessed usingImage J analysis software (NIH, public domain). To gener-
ate a quantitative measure of profile shape, diameter of
mitochondrial profiles at the longest extent was measured,
followed by a second similar measurement perpendicu-
lar to the first and through the midline. These values
were used to generate a ratio which reflected how circu-
lar or elliptical a mitochondrial profile was, with a ratio
of 1.0 denoting a circle, while higher ratios represented
increasingly elliptical profiles.
The location of mitochondria within images of trans-
verse sections was defined morphologically as either
‘axonal’ or ‘glial’, the latter of which denoted any mi-
tochondrion not clearly within an axon (Figure 1B).
Further, mitochondrial profiles exhibiting features of
mitochondrial autophagy [57] were separately quantified.
To generate mitochondrial density values, the area of
glial processes was measured in every field of view and a
sum of these areas was generated per animal. Glial mito-
chondrial density was derived by dividing the number of
mitochondria in glia in all fields of view for each animal
by the total area of the glial compartment. Axonal mito-
chondrial density was calculated similarly, by subtracting
the glial areas from the total fields of view to provide the
axonal areas. The axonal area therefore includes myelin
as well as small spaces between axons.
Enzyme activity assays: tissue preparation
Activities of the two mitochondrial enzymes, aconitase
and citrate synthase, were assessed in ONs from a sec-
ond cohort of animals. Changes in enzyme activities as a
consequence of secondary degeneration were assessed in
four groups (n = 6/group): Normal, day 1, day 7 and day
28 after injury. The effect of R/NIR-IT on the activity of
these enzymes following injury was evaluated in a separ-
ate group of animals at days 1 and 7: at each time point
there was a PT handled control group and a PT 670 nm
light treatment group (n = 6/group). To collect tissue,
following anaesthesia, the ON was accessed as for PT
surgery and a 2 mm segment of ON containing the le-
sion site (or similar area for normal controls) rapidly re-
moved onto a microscope slide on a metal plate over dry
ice. The ON segments were dissected into dorsal and
ventral halves longitudinally, while viewed under a
dissecting microscope, and dorsal or ventral halves
pooled for each group, snap frozen in liquid nitrogen
and stored at −80°C. The dissection procedure was ac-
complished in less than 2 min. Thus assays were
conducted on a single tissue sample (comprising pooled
optic nerve segments from 6 animals) for each experi-
mental group.
Mitochondrial aconitase activity assay
Mitochondrial aconitase activity was determined using an
assay kit (Abcam, Cambridge, UK, ab83459), according to
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ventral ONs were homogenised in the supplied assay buf-
fer on ice in a glass Dounce homogeniser, homogenates
centrifuged at 800 g for 10mins at 4°C to remove nuclei
and gross cellular debris, and the resultant supernatant
further centrifuged at 20,000 g for 15 minutes at 4°C in
an ultracentrifuge (Optima TLX, Beckman-Coulter) to
collect the mitochondrial fraction. The pellets were
dissolved into 0.1 ml of cold assay buffer, sonicated for
20 s in a water bath (Branson 3210) and stored at −80°C
until assayed. Aconitase activity was determined in trip-
licate by comparison to a standard curve, and expressed
in mU, where one unit of aconitase is the amount of en-
zyme that will isomerise 1 μmol of citrate to isocitrate
per min at pH 7.4 at 25°C.
Citrate synthase activity assay
After homogenisation on ice in Cell Lytic buffer (Sigma-
Aldrich Co., St. Louis, MO) as described above, ON sam-
ples were assayed for citrate synthase in triplicate using an
assay kit (Sigma, CS0720), according to the manufacturer’s
instructions. Citrate synthase activity was expressed in
μmol/min. Results for both enzyme assays were
expressed/mg protein; based on the pellets of the first cen-
trifugation after homogenisation, due to the limitations of
ON homogenate volumes (Thermo Scientific).
Statistical analyses
Mean mitochondrial densities, areas and shapes, as
reflected by the ratio of diameters, were assessed with
one-way ANOVA in SPSS (version 20, IBM). Homogen-
eity of variance was confirmed using Levene’s test. Fre-
quency distributions for mitochondrial area and shape
were generated and a modified version of the two-
sample Kolmogorov-Smirnov (KS) test was used to
determine statistically significant differences between
distributions in R stat (version 2.15). The modification
of the KS test used a permutation analysis (re-sampling
without replacement, repetitions = 5000) to accurately ad-
dress whether experimental condition was non-randomly
associated with the measured distributions, without mak-
ing assumptions about the nature of the underlying error
distribution [58]. Permutations were carried out at the
level of animals to avoid pseudo-replication. The per-
mutation approach is based on the assumption that if
there is no association between treatment and mito-
chondrial area/shape, then permuting or randomising
this association will, on average, not change the test
statistic (d) calculated by the KS test. Statistical signifi-
cance was then assessed as the probability of obtaining
a d-value in the randomised samples that is as or more
extreme than the d-value generated by the measured
dataset, with p ≤ 0.05 being considered statistically sig-
nificant. Pair-wise comparisons were limited to threespecific questions associated with our hypotheses; spe-
cifically, changes with injury only, changes in injured
animals following R/NIR-IT, and comparison of treated
to normal animals.
Data for observations of mitochondrial autophagic
profiles were analysed in the context of a regression ana-
lysis, due to the high variability, lack of clear demonstra-
tion of normal distributions and the non-factorial study
design. We used the same permutation approach as de-
scribed above, with the test statistic being the F-statistic
of the parameter in question. As in a typical regression
analysis, the significance of each model term was judged
by comparing models that differed by only one term. As
such, this analysis incorporated the variation found in all
experimental groups and was not limited to pair-wise
comparisons. Data for day 1 and day 7 were analysed
separately, using the same normal control group for
comparison. This analysis was performed in MATLAB®
version R2012a (MathWorks).
For the enzyme assays, statistically significant differ-
ences between groups were determined by multivariate
ANOVA (MANOVA) in SPSS, with activity in dorsal
and ventral optic nerve as dependent variables and time
point (day 1, day 7, day 28) and treatment (PT handled,
PT 670 nm) as between subjects factors, with subse-
quent follow-up ANOVAs and Bonferroni post hoc tests
as appropriate. Values for the test statistic Pillai’s trace
(V) and follow-up ANOVAs (F) are provided, with p ≤
0.05 being considered statistically significant.
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